ICU Medical, Inc. (ICUI)

NasdaqGS · Medical Instruments & Supplies

183.59
+1.08 (+0.59%)
Updated Aug 18, 4:04 PM ET
AI Rating
Buy
Overall Score
72
Trend
75
Momentum
88
Risk
44

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 19, 2026 120 sessions Aug 14, 2026

AI Analysis

ICU Medical, Inc. is trading at $183.59, up 0.59% on the session. The 50 day average sits at $154.23 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 68.3, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $164.09 with resistance near $192.85, so that band frames the current range. Average daily movement is roughly $6.04, or about 3.3% of the share price, which is what any stop placement has to allow for. The overall health score of 72 out of 100 combines a trend score of 75, momentum of 88 and a risk score of 44.

Technical indicators

RSI (14)
68.3
strong
MACD
8.442
bullish crossover
SMA 20
169.01
SMA 50
154.23
SMA 200
--
unknown
ATR (14)
6.04
avg daily range
Support
164.09
Resistance
192.85
Volume vs 20d
0.54x
below average
Volatility
47.4%
annualised
1 month
+16.10%
3 months
+46.76%

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.